A carregar...

Preclinical characterization of DUOC-01, a cell therapy product derived from banked umbilical cord blood for use as an adjuvant to umbilical cord blood transplantation for treatment of inherited metabolic diseases

BACKGROUND AIMS: Cord blood (CB) transplantation slows neurodegeneration during certain inherited metabolic diseases. However, the number of donor cells in the brain of patients does not appear to be sufficient to provide benefit until several months after transplant. We developed the cell product D...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cytotherapy
Main Authors: KURTZBERG, JOANNE, BUNTZ, SUSAN, GENTRY, TRACY, NOELDNER, PAMELA, OZAMIZ, APRIL, RUSCHE, BENJAMIN, STORMS, ROBERT W., WOLLISH, AMY, WENGER, DAVID A., BALBER, ANDREW E.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4843803/
https://ncbi.nlm.nih.gov/pubmed/25770677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcyt.2015.02.006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!